Literature DB >> 18366950

Use of pharmacy refill data as a measure of antiretroviral adherence.

Robert Grossberg1, Robert Gross.   

Abstract

Pharmacy refill adherence has become an increasingly important measure of adherence to antiretroviral medications. It offers a simple, inexpensive, and valid method for measuring adherence. Over the past year, there have been several published developments in the use of pharmacy refill data to measure adherence. Given the utility of this adherence measurement, it is likely that pharmacy refill will be the method of choice for measuring antiretroviral adherence in an increasing number of clinical and research settings.

Mesh：

Substances：

Year:  2007        PMID： 18366950     DOI： 10.1007/s11904-007-0027-4

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


  21 in total

1.  The impact of adherence on CD4 cell count responses among HIV-infected patients.

Authors:  Evan Wood; Robert S Hogg; Benita Yip; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2004-03-01       Impact factor: 3.731

2.  Medication refill logistics and refill adherence in HIV.

Authors:  R Gross; Y Zhang; R Grossberg
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-11       Impact factor: 2.890

3.  Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort.

Authors:  Paula Braitstein; Amy Justice; David R Bangsberg; Benita Yip; Victoria Alfonso; Martin T Schechter; Robert S Hogg; Julio S G Montaner
Journal:  AIDS       Date:  2006-02-14       Impact factor: 4.177

4.  Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Melanie Lo; Saad B Omer; Leon Regensberg; Richard E Chaisson; Gary Maartens
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

Review 5.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.

Authors:  J F Steiner; A V Prochazka
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

6.  Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Authors:  Jean B Nachega; Michael Hislop; David W Dowdy; Richard E Chaisson; Leon Regensberg; Gary Maartens
Journal:  Ann Intern Med       Date:  2007-04-17       Impact factor: 25.391

7.  Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users.

Authors:  Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg
Journal:  CMAJ       Date:  2003-09-30       Impact factor: 8.262

8.  Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users.

Authors:  Evan Wood; Julio S G Montaner; Benita Yip; Mark W Tyndall; Martin T Schechter; Michael V O'Shaughnessy; Robert S Hogg
Journal:  Antivir Ther       Date:  2004-04

9.  A general method of compliance assessment using centralized pharmacy records. Description and validation.

Authors:  J F Steiner; T D Koepsell; S D Fihn; T S Inui
Journal:  Med Care       Date:  1988-08       Impact factor: 2.983

10.  Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.

Authors:  Evan Wood; Robert S Hogg; Benita Yip; P Richard Harrigan; Michael V O'Shaughnessy; Julio S G Montaner
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391
View more
  37 in total

1.  If You Build It, Will They Use It? Preferences for Antiretroviral Therapy (ART) Adherence Monitoring Among People Who Inject Drugs (PWID) in Kazakhstan.

Authors:  Alissa Davis; Lyailya Sarsembayeva; Valeriy Gulyaev; Sholpan Primbetova; Assel Terlikbayeva; Gaukhar Mergenova; Robert H Remien
Journal:  AIDS Behav       Date:  2019-12

2.  Implementing electronic substance use disorder and depression and anxiety screening and behavioral interventions in primary care clinics serving people with HIV: Protocol for the Promoting Access to Care Engagement (PACE) trial.

Authors:  Derek D Satre; Alexandra N Anderson; Amy S Leibowitz; Tory Levine-Hall; Sally Slome; Jason Flamm; C Bradley Hare; Jennifer McNeely; Constance M Weisner; Michael A Horberg; Paul Volberding; Michael J Silverberg
Journal:  Contemp Clin Trials       Date:  2019-08-22       Impact factor: 2.226

3.  Antihypertensive Medication in Patients Pre- and Postdialysis: Still Hazy After All These Years.

Authors:  Jordana B Cohen; Raymond R Townsend
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-27       Impact factor: 8.237

4.  Real-time electronic adherence monitoring is feasible, comparable to unannounced pill counts, and acceptable.

Authors:  Jessica E Haberer; Gregory K Robbins; Michele Ybarra; Alexandra Monk; Kathleen Ragland; Sheri D Weiser; Mallory O Johnson; David R Bangsberg
Journal:  AIDS Behav       Date:  2012-02

5.  Rural residence and adoption of a novel HIV therapy in a national, equal-access healthcare system.

Authors:  Michael Ohl; Brian Lund; Pamela S Belperio; Matthew Bidwell Goetz; David Rimland; Kelly Richardson; Amy Justice; Eli Perencevich; Mary Vaughan-Sarrazin
Journal:  AIDS Behav       Date:  2013-01

6.  Employing the FITT framework to explore HIV case managers' perceptions of two electronic clinical data (ECD) summary systems.

Authors:  Rebecca Schnall; Ann B Smith; Manik Sikka; Peter Gordon; Eli Camhi; Timothy Kanter; Suzanne Bakken
Journal:  Int J Med Inform       Date:  2012-07-28       Impact factor: 4.046

7.  Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV.

Authors:  Karen S Ingersoll; Rebecca A Dillingham; Jennifer E Hettema; Mark Conaway; Jason Freeman; George Reynolds; Sharzad Hosseinbor
Journal:  Health Psychol       Date:  2015-12       Impact factor: 4.267

8.  Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors.

Authors:  Man Charurat; Modupe Oyegunle; Renata Benjamin; Abdulrazaq Habib; Emeka Eze; Prince Ele; Iquo Ibanga; Samuel Ajayi; Maria Eng; Prosanta Mondal; Usman Gebi; Emilia Iwu; Mary-Ann Etiebet; Alash'le Abimiku; Patrick Dakum; John Farley; William Blattner
Journal:  PLoS One       Date:  2010-05-11       Impact factor: 3.240

9.  Medication understanding, non-adherence, and clinical outcomes among adult kidney transplant recipients.

Authors:  Rachel E Patzer; Marina Serper; Peter P Reese; Kamila Przytula; Rachel Koval; Daniela P Ladner; Josh M Levitsky; Michael M Abecassis; Michael S Wolf
Journal:  Clin Transplant       Date:  2016-08-29       Impact factor: 2.863

10.  Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.

Authors:  Adriana S A Andrade; Reena Deutsch; Shivaun A Celano; Nichole A Duarte; Thomas D Marcotte; Anya Umlauf; J Hampton Atkinson; J Allen McCutchan; Donald Franklin; Terry J Alexander; Justin C McArthur; Christina Marra; Igor Grant; Ann C Collier
Journal:  J Acquir Immune Defic Syndr       Date:  2013-03-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.